DK1494746T3 - Insulin til anvendelse i en dosering - Google Patents

Insulin til anvendelse i en dosering

Info

Publication number
DK1494746T3
DK1494746T3 DK03723801.1T DK03723801T DK1494746T3 DK 1494746 T3 DK1494746 T3 DK 1494746T3 DK 03723801 T DK03723801 T DK 03723801T DK 1494746 T3 DK1494746 T3 DK 1494746T3
Authority
DK
Denmark
Prior art keywords
subject
glucose
insulin
processing
restored
Prior art date
Application number
DK03723801.1T
Other languages
English (en)
Inventor
Thomas T Aoki
Original Assignee
Thomas T Aoki
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomas T Aoki filed Critical Thomas T Aoki
Application granted granted Critical
Publication of DK1494746T3 publication Critical patent/DK1494746T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • A61M5/145Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons
    • A61M5/1452Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons pressurised by means of pistons
    • A61M5/1456Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons pressurised by means of pistons with a replaceable reservoir comprising a piston rod to be moved into the reservoir, e.g. the piston rod is part of the removable reservoir
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • A61M2005/14208Pressure infusion, e.g. using pumps with a programmable infusion control system, characterised by the infusion program
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/35Communication
    • A61M2205/3576Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
    • A61M2205/3592Communication with non implanted data transmission devices, e.g. using external transmitter or receiver using telemetric means, e.g. radio or optical transmission
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00Measuring parameters of the user
    • A61M2230/20Blood composition characteristics
    • A61M2230/201Glucose concentration
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection

Landscapes

  • Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • External Artificial Organs (AREA)
DK03723801.1T 2002-03-29 2003-03-19 Insulin til anvendelse i en dosering DK1494746T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002094534 2002-03-29
JP2002377961A JP4177659B2 (ja) 2002-03-29 2002-12-26 インスリンを注入する装置
PCT/US2003/008781 WO2003084459A2 (en) 2002-03-29 2003-03-19 Device for infusing insulin

Publications (1)

Publication Number Publication Date
DK1494746T3 true DK1494746T3 (da) 2011-08-29

Family

ID=28793508

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03723801.1T DK1494746T3 (da) 2002-03-29 2003-03-19 Insulin til anvendelse i en dosering

Country Status (8)

Country Link
EP (1) EP1494746B1 (da)
JP (1) JP4177659B2 (da)
CN (1) CN100591387C (da)
AT (1) ATE509650T1 (da)
AU (1) AU2003230711B2 (da)
CA (1) CA2480572C (da)
DK (1) DK1494746T3 (da)
WO (1) WO2003084459A2 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2362420T3 (es) * 2002-03-29 2011-07-05 Thomas T. Aoki Insulina para uso en un régimen de dosificación.
EP1593403A1 (en) * 2004-05-06 2005-11-09 Bionica International NV Medical device for quantitatively and chronologically sequenced infusion delivery
JP4807774B2 (ja) 2005-10-20 2011-11-02 日東電工株式会社 液晶パネルおよび液晶表示装置
US7941200B2 (en) * 2005-12-08 2011-05-10 Roche Diagnostics Operations, Inc. System and method for determining drug administration information
CN102648992B (zh) * 2011-02-24 2013-11-20 上海微创生命科技有限公司 一种胰岛素输注控制装置
WO2012141764A2 (en) 2011-04-12 2012-10-18 Aoki Thomas T Pre-operative use of metabolic activation therapy

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4469681A (en) * 1979-07-31 1984-09-04 The Rockefeller University Method and system for the controlled release of biologically active substances to a body fluid
US4435173A (en) * 1982-03-05 1984-03-06 Delta Medical Industries Variable rate syringe pump for insulin delivery
US4498843A (en) * 1982-08-02 1985-02-12 Schneider Philip H Insulin infusion pump
WO1985002544A1 (en) * 1983-12-16 1985-06-20 Thomas Takemi Aoki Insulin delivery algorithm
US4826810A (en) 1983-12-16 1989-05-02 Aoki Thomas T System and method for treating animal body tissues to improve the dietary fuel processing capabilities thereof
US5956501A (en) * 1997-01-10 1999-09-21 Health Hero Network, Inc. Disease simulation system and method
US5665065A (en) * 1995-05-26 1997-09-09 Minimed Inc. Medication infusion device with blood glucose data input
US7267665B2 (en) * 1999-06-03 2007-09-11 Medtronic Minimed, Inc. Closed loop system for controlling insulin infusion
US6558351B1 (en) * 1999-06-03 2003-05-06 Medtronic Minimed, Inc. Closed loop system for controlling insulin infusion
US6554798B1 (en) * 1998-08-18 2003-04-29 Medtronic Minimed, Inc. External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities
CN2402333Y (zh) * 1999-12-24 2000-10-25 王秀琪 开环式持续皮下输注胰岛素装置
US20030055380A1 (en) * 2001-09-19 2003-03-20 Flaherty J. Christopher Plunger for patient infusion device

Also Published As

Publication number Publication date
HK1068824A1 (en) 2005-05-06
EP1494746B1 (en) 2011-05-18
AU2003230711A1 (en) 2003-10-20
WO2003084459A2 (en) 2003-10-16
CA2480572C (en) 2012-02-21
JP4177659B2 (ja) 2008-11-05
CN100591387C (zh) 2010-02-24
EP1494746A4 (en) 2007-01-17
AU2003230711B2 (en) 2008-07-03
EP1494746A2 (en) 2005-01-12
ATE509650T1 (de) 2011-06-15
CA2480572A1 (en) 2003-10-16
JP2004000461A (ja) 2004-01-08
CN1655842A (zh) 2005-08-17
WO2003084459A3 (en) 2004-04-01

Similar Documents

Publication Publication Date Title
WO2006062559A3 (en) Device for enhancing tissue glucose processing
ES2569949T3 (es) Formulaciones farmacéuticas que comprenden un péptido complejado con una dicetopiperazina
MXPA05007470A (es) Metodo para reducir la morbilidad y mortalidad cardiovascular en pacientes prediabeticos y pacientes con diabetes de tipo 2.
ATE194462T1 (de) Steigerung der kreatin und glykogen konzentration im muskel
WO2005012485A3 (en) Methods for treating diabetes and related disorders using pde10a inhibitors
UA42061C2 (uk) Фармацевтична композиція для перорального введення, що містить інгібітори протонного насоса
HRP20120688T1 (hr) Re“im doziranja u liječenju traumatske ozljede mozga progesteronom
EP2135603A3 (en) Compositions and methods for increasing insulin sensitivity
PT1207756E (pt) Utilizacao de espinosade ou de uma formulacao que compreende espinosade
ATE71291T1 (de) Pharmazeutische zubereitung mit verzoegerter freigabe.
DK1494746T3 (da) Insulin til anvendelse i en dosering
BR0308229A (pt) Medicamentos contendo ingredientes ativos que diminuem o nìvel de colesterol com liberação do ingrediente ativo de tempo tardio
DE50012735D1 (de) Verwendung eines modifizierten kohlenhydrats
Cronstein Going with the flow: methotrexate, adenosine, and blood flow
BRPI0409699A (pt) métodos de indução do efeito diurético, de indução, manutenção ou restauração do efeito diurético de diurético não modificador de adenosina, de manutenção, restauração ou melhoria da função renal em paciente, de indução de diurese, de prevenção do inìcio de deficiência renal em paciente com sobrecarga de fluidos ou chf, de tratamento de paciente que sofre de chf e de melhoria dos resultados globais da saúde, composição farmacêutica e seus usos
DE602004024221D1 (de) Behandlung von entzündlichen darmerkrankungen mit 2-methylen-19-nor-vitamin d verbindungen
ITRM20030596A1 (it) Uso di inibitori della pentraxina lunga ptx3, per la preparazione di un medicamento per la prevenzione e cura di patologie che rispondono all'inibizione dell'attivita' biologica di detta ptx3.
WO2001005955A3 (en) Animals comprising human hepatocellular tissue
Altuntaş Approach toward diabetes treatment in the elderly
GR1004641B (el) Μορφηαφαρμακευτικησαδοσολογιασαπουαφερειαφιλικεσαπροσατηνακυησηαενδειξεισαα
RU2002116408A (ru) Способ реперфузионной терапии больных острым инфарктом миокарда
RU2003112502A (ru) Адаптогенный лекарственный препарат для перорального применения
Bakshtanovskaia et al. Impact of anthelminthic therapy for opisthorchiasis on the biochemical parameters of hepatic function
Ramam Response by Dr. Ramam
Flynn et al. Exaggerated weight loss in genetically obese (ob/ob) mice by withdrawal from morphine